Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
8461
-
8462
-
8463
-
8464
Migration of DLD1 cells 24 h and 48 h after 17β-estradiol (E2) administration.
Published 2023Subjects: -
8465
-
8466
-
8467
C5a concentration throughout the study period.
Published 2014“…<p>The C5a levels decreased significantly during the three months of zinc supplementation and returned to baseline level within 2 months after the cessation of zinc supplementation.…”
-
8468
-
8469
-
8470
-
8471
-
8472
-
8473
Multiple homologs of 16p12.1 genes contribute to neurodevelopmental defects in <i>Drosophila melanogaster</i> and <i>X</i>. <i>laevis</i>.
Published 2021“…Knockdown of <i>cdr2</i> (n = 54, two-tailed student’s t-test, *p = 7.75 ×10<sup>−4</sup>), <i>polr3e</i> (n = 37, *p = 1.97 ×10<sup>−13</sup>) and <i>mosmo</i> (n = 50, *p = 1.36 ×10<sup>−11</sup>) led to decreased face width, while knockdown of <i>polr3e</i> (*p = 3.29 ×10<sup>−16</sup>) and <i>mosmo</i> (*p = 1.47 ×10<sup>−8</sup>) led to decreased orofacial area. …”
-
8474
-
8475
Neutralization of point mutants of B.1.351 and D614G spike-pseudotyped lentiviral particles by convalescent plasmas from B.1.351 and early 2020-infected individuals.
Published 2022“…<b>(B)</b> The fold-decrease in neutralization for samples shown in <b><a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.g005" target="_blank">Fig 5</a></b>, with the addition of previously measured neutralization by samples from 6 early 2020 convalescent individuals collected approximately 100 days post-symptom onset [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.ref038" target="_blank">38</a>]. …”
-
8476
-
8477
-
8478
-
8479
DataSheet_1_Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.pdf
Published 2023“…Background<p>Immune-evading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging continuously. The clinical effectiveness of monoclonal antibody agents that exhibit decreased in vitro activity against SARS-CoV-2 variants needs to be elucidated.…”
-
8480